文献速递前列腺增生与排尿功能障碍

一种识别男性和女性下尿路症状相关血清和尿液生物标志物及通路的新型蛋白质组学方法:下尿路功能障碍症状研究网络(LURN)研究的初步结果

A Novel Proteomics Approach to Identify Serum and Urinary Biomarkers and Pathways that Associate with Lower Urinary Tract Symptoms in Men and Women: Pilot Results of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Study.
PubMed 文献 · Urology · 2019-03-25

该初步研究随机选取有下尿路症状(LUTS)的18名男性和18名女性,并匹配12名男性和12名女性对照,用SomaScan检测血清和尿液中1305种蛋白。血清重复性优于尿液,男性病例对照间差异蛋白多于女性,男性富集通路与前列腺形态发生相关,女性与生长和炎症相关。作者认为LUTS病因可能具有性别特异性。

要点

  • SomaScan在血清中的重复性优于尿液。
  • 男性病例与对照间的差异蛋白数量多于女性。
  • 男性富集通路与前列腺形态发生相关,女性与生长和炎症相关。

核心结论

  • 初步研究结果支持LUTS的病因和病理生理机制可能具有性别特异性。
  • 虽然需要更大样本的进一步研究,但结果支持新型蛋白质组学方法用于LUTS诊断分类生物标志物识别的可行性。

研究设计与样本

  • 从LURN观察性队列研究中随机选取有LUTS的18名男性和18名女性(用LUTS Tool问卷测量),并招募匹配临床人口学特征的12名男性和12名女性对照(极少或无LUTS)。
  • 使用SomaScan Assay(SomaLogic)测量尿液和血清中1305种蛋白的丰度。
  • 进行统计分析以评估检测重复性、比较蛋白丰度并估计效应量。

主要发现

  • SomaScan检测结果在血清中的重复性高于尿液。
  • 在血清中,男性病例与对照之间的差异丰度蛋白数量远多于女性。
  • 对男性和女性受影响蛋白的富集/通路分析显示,富集的基因本体过程在男性中与前列腺形态发生相关,在女性中与生长和炎症相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需要涉及更大数量受试者的进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the feasibility of a novel proteomics approach to identify biomarkers associated with lower urinary tract symptoms (LUTS) within serum and urine, because many clinical factors contribute to LUTS in men and women. These factors confound clinicians' abilities to reliably evaluate and treat LUTS. Previous studies identified candidate LUTS biomarkers, but none are clinically utilized. METHODS: Eighteen male and 18 female symptoms of lower urinary tract dysfunction research network (LURN) observational cohort study participants with LUTS (measured on the LUTS Tool questionnaire) were randomly selected. Twelve male and 12 female controls with minimal or no LUTS were recruited and matched for clinico-demographic characteristics. The SomaScan Assay (SomaLogic) was used to measure the abundance of 1305 proteins contained within urine and serum. Statistical analyses were performed to evaluate reproducibility of assays, compare protein abundances, and estimate effect size. RESULTS: SomaScan assay results were more reproducible in serum than in urine. Within serum, there were many more differentially abundant proteins between cases and controls in males than in females. An enrichment/pathway analysis of the affected proteins in male and female subjects demonstrated that the enriched Gene Ontology processes were related to prostate morphogenesis in men and growth and inflammation in women. CONCLUSION: The pilot study results support that the etiology and pathophysiologic mechanisms underlying LUTS may be sex-specific. While further studies involving larger numbers of subjects are warranted, our results support the feasibility of a novel proteomic approach to identify biomarkers for diagnostic classification of LUTS.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Helfand BT, Andreev VP, Siddiqui NY, et al. A Novel Proteomics Approach to Identify Serum and Urinary Biomarkers and Pathways that Associate with Lower Urinary Tract Symptoms in Men and Women: Pilot Results of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Study. Urology. 2019. PMID: 30922973. doi:10.1016/j.urology.2019.03.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。